ロード中...
Modified FOLFIRINOX for resected pancreatic cancer: Opportunities and challenges
Pancreatic cancer is one of the leading causes of cancer death worldwide. Adjuvant chemotherapy has been developed based on the experiences made with palliative chemotherapy, and advocated to improve long-term survival of patients with this disease. However, the optimal chemotherapeutic regimen rema...
保存先:
| 出版年: | World J Gastroenterol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6589737/ https://ncbi.nlm.nih.gov/pubmed/31249443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i23.2839 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|